The approval process for antibody therapy against COVID-19 is still pending in the EU

0
1


<

div>






<a href="https://www.de24.news/"></a> The  approval process for antibody therapy against COVID-19 is still pending in the EU















Antibody therapies against COVID-19 that have already been approved in the USA are still a long time coming in the EU. So far, there is no approval process at the European Medicines Agency (EMA) for any of the funds, as can be seen from the information on the authorities’ website.

Complicated and expensive production

Antibody therapies against COVID-19 that have already been approved in the USA are still a long time coming in the EU. So far, there is no approval process at the European Medicines Agency (EMA) for any of the funds, as can be seen from the information on the authorities’ website. In the US, two such therapies have had emergency approval since November. © www.de24.news The y are based on monoclonal antibodies, which are produced in the laboratory and disable the virus after infection.

© www.de24.news

 The  funds from Regeneron and Eli Lilly may be used in the USA to treat patients aged twelve and over who are at risk of developing severe COVID-19 symptoms. According to Regeneron, the greatest beneficiaries are test persons whose immune systems have not yet produced their own antibodies against the virus.

According to a spokeswoman, Regeneron plans to also apply for approvals in the EU together with the pharmaceutical company Roche as a partner. Eli Lilly and other companies are likely to follow.

© www.de24.news

 The  Frankfurt virologist Sandra Ciesek assumes – also because of the complicated and expensive production – that “this is probably more of an operation that will be very controlled, for example with high-risk patients, but will certainly not be feasible for everyone”.





Esanum is an online network for approved doctors

Esanum is the medical platform on the Internet. Here, doctors have the opportunity to get in touch
with a
multitude of colleagues and to share interdisciplinary experiences. Discussions include both cases
and
observations from practice, as well as news and developments from everyday medical practice.

Esanum is an online network for licensed doctors

Esanum is the online medical platform. Here doctors have the opportunity to get in touch with a large number of colleagues and to exchange interdisciplinary experiences. Discussions include cases and observations from practice as well as news and developments from everyday medical practice.

Esanum is an online network for licensed physicians

Esanum is a social network for doctors. Join the community and share your experience with your colleagues. Health news, reports of scientific studies and medical conferences: find all the news of your medical specialty on esanum.



<

noscript>
<img height=”1″ width=”1″ ” alt=”” src=”https://px.ads.linkedin.com/collect/?pid=1386697&fmt=gif”/>





[ source link ]
https://www.esanum.de/today/posts/zulassungsprozess-fuer-antikoerpertherapie-gegen-covid-19-bleibt-in-eu-weiter-aus

approval process antibody therapy COVID19 pending

LEAVE A REPLY

Please enter your comment!
Please enter your name here